Page 1 of Clinical Trials for Repros Therapeutics Inc. [SPONSOR-COLLABORATORS], 34 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Terminated
Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids
Last Updated: February 10, 2010
Condition(s): Uterine Fibroids; Anemia
2
Withdrawn
To Evaluating the Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms in Premenopausal Women
Last Updated: February 10, 2010
Condition(s): Uterine Fibroids
3
Completed
Proellex® Pharmacokinetic Bridging Study II
Last Updated: February 8, 2010
Condition(s): Healthy
4
Active, not recruiting
The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)
Last Updated: October 13, 2011
Condition(s): Hypogonadism; Low Testosterone
5
Completed
Proellex Pharmacokinetics Bridging Study
Last Updated: February 10, 2010
Condition(s): Healthy
6
Terminated
Study to Evaluate Menses Induction in Women Administered Proellex
Last Updated: February 10, 2010
Condition(s): Amenorrhea
7
Not yet recruiting
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Last Updated: April 24, 2012
Condition(s): Secondary Hypogonadism; Low Testosterone
8
Terminated
Study Evaluating the Safety and Efficacy of the Selective Progesterone Receptor Modulator Proellex® in the Treatment of Premenopausal Women With Symptomatic Endometriosis-extension Study
Last Updated: February 10, 2010
Condition(s): Endometriosis
9
Not yet recruiting
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
Last Updated: April 24, 2012
Condition(s): Secondary Hypogonadism; Low Testosterone
10
Terminated
Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids
Last Updated: February 10, 2010
Condition(s): Uterine Fibroids
11
Terminated
Evaluate PK and Safety of Proellex® in Females With Various Stages of Impaired Renal Function and Healthy Females
Last Updated: August 25, 2010
Condition(s): Renal Function
12
Completed
To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone
Last Updated: June 29, 2011
Condition(s): Infertility in Men; Secondary Hypogonadism
13
Terminated
A Study Evaluating the Safety of 25 and 50 mg Proellex® (CDB-4124) in the Treatment of Premenopausal Women With Symptomatic Uterine Fibroids
Last Updated: February 16, 2010
Condition(s): Uterine Fibroids
14
Active, not recruiting
Exploratory Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus and Secondary Hypogonadism or Adult-Onset Idiopathic Hypogonadotropic Hypogonadism
Last Updated: August 31, 2011
Condition(s): Type 2 Diabetes Mellitus; Secondary Hypogonadism
15
Recruiting
Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids
Last Updated: April 23, 2012
Condition(s): Uterine Fibroids
16
Completed
Two Year Extension Study of the Selective Progesterone Receptor Modulator Proellex® (CDB-4124) in Pre-Menopausal Women With Symptomatic Leiomyomata Who Have Previously Completed Study ZPU 003
Last Updated: December 9, 2010
Condition(s): Uterine Fibroids
17
Completed
Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism
Last Updated: February 10, 2010
Condition(s): Secondary Hypogonadism
18
Active, not recruiting
Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism (Low Testosterone), That Wish to Maintain Their Reproductive Status
Last Updated: August 31, 2011
Condition(s): Secondary Hypogonadism; Preservation of Reproductive Status
19
Active, not recruiting
Determination of the Lowest, Safe and Effective Dose of the Anti-Progestin, Proellex, in Healthy Women
Last Updated: February 9, 2012
Condition(s): Amenorrhea
20
Terminated
Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids
Last Updated: February 10, 2010
Condition(s): Uterine Fibroids

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Repros+Therapeutics+Inc.

Page 1 of Clinical Trials for Repros Therapeutics Inc. [SPONSOR-COLLABORATORS], 34 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About